International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-2 doi: 10.5281/zenodo.14986519
Original Research Article
Histopathological Analysis of Testicular Lesions in Tertiary Care Center
Published
March 6, 2025
Abstract

Introduction:Testicular tumors are relatively rare malignancies that primarily affect young men, typically between the ages of 20 and 40 years. Testicular lesions requiring orchidectomy can be both neoplastic and non-neoplastic conditions. Non-neoplastic lesions are more prevalent than neoplastic ones. Incidence rates of testicular tumors show considerable geographical variation, and interestingly, they exhibit aninverse pattern to most cancers, with decreasing incidence as age increases. Surgical removal of the affected testis (orchiectomy) remains the cornerstone of treatment, often followed by chemotherapy or radiation, depending on the stage and histology. Material and Method: This was a retrospective study, in which total 30 testicular cases were retrieved from database between July 2022 to June 2023, in the department of pathology, SMIMER, Surat. Results: There was a total of 30 specimens received in the department of pathology, during the study period. 30%(9 specimen) of the total specimen does not have definite diagnosis(descriptive), 16.6% (5 specimen) was of torsion of testis, 13.3% (4 specimen) was of cryptorchidism, 6.6% (2 specimen) was of atrophy of testis, 6.6% (2 specimen) was of inflammation of testis, 6.6%(2 specimen) was of granulomatous inflammation of testis, 6.6% (2 specimen) was of ectopic testis, 3.3% (1 specimen) was of classic seminoma, 3.3% (1 specimen) was of spermatolytic tumor, 3.3%(1 specimen) was of Leydig cell tumor, 3.3% (1 specimen) was of Germ cell tumors derived from germ cell neoplasia in situ (GCNIS) - mixed Germ cell tumor- Teratoma- post pubertal type (Immature teratoma) (70%) + Yolk sac tumor (30%). Conclusion: Testicular tumors are uncommon in our population.Non-neoplastic lesions are more prevalent than neoplastic ones. According to new WHO classification 2022 5 th edition there are new changes. These are the changes. Spermatocytic tumor and seminoma both are germ cell tumors. Spermatocytic tumor is included in Germ cell tumor unrelated to germ cell neoplasia in situ. Seminoma is included in Germ cell tumors derived from germ cell neoplasia in situ (GCNIS).

Recommended Articles
Loading Image...
Volume-6, Issue-2
Citations
165 Views
323 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved